Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Study on Individualized Neoadjuvant Treatment Regimens for Early HR+/HER2+ Breast Cancer

NCT07300215 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Bengbu Medical University as lead sponsor.

NCT NCT07300215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07300215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Study on Individualized Neoadjuvant Treatment Regimens for Early HR+/HER2+ Breast Cancer
Lead sponsor
The First Affiliated Hospital of Bengbu Medical University
Phase
Phase 2
Overall status
Not yet recruiting
Start date
December 20, 2025
Completion date
November 1, 2027
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer